|View printer-friendly version|
|September 12, 2002 4:20 p.m.|
|Judge Grants Teva Summary Judgment of Invalidity for Patent Related to Hydrocodone Bitartrate and Ibuprofen Tablets|
Jerusalem, Israel, September 12, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the Honorable John W. Darrah, U. S. District Court Judge for the Northern District of Illinois, Eastern Division has granted Teva's motion for summary judgment of invalidity finding U. S. Patent (No. 4,587,252), relating to a combination of hydrocodone and ibuproen, invalid. The FDA has been informed of the judge's order and Teva is hopeful that its ANDA, which was made under Paragraph IV of the Hatch-Waxman Act, will receive final approval shortly.